Phoenix Life Sciences completes consolidation of businesses

In This List

Blog

Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns

Blog

Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders

Blog

Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up

Blog

Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps

2 Nov, 2018

Author Muhammad Hammad Asif
Theme Healthcare & Pharmaceuticals

Phoenix Life Sciences International Ltd. completed the consolidation of multiple domestic and international businesses, which included Stem BioScience Inc., Blue Dragon Ventures and the MediJane brand.

Denver-based Phoenix Life Sciences also received approval from the Financial Industry Regulatory Authority to complete the change in name and stock symbol in connection with the consolidation of businesses, and will now trade on the OTC Pink Market under the symbol PLSI.